Adjacent segment degeneration (ASD) after spondylodesis M53.9
Conditions
Interventions
Group 1: The following scores are collected once from patients who underwent symptomatic ASD extensions of their existing spondylodeses within the clinic between 2014 and 2022:
VAS pain (Visual Analog
Sponsors
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - All patients who were treated with a follow-up spondylodesis as part of an ASD from 2014 to 2022 - m/f/d - Age over 18 years
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective of the study project is defined as the assessment of the clinical outcome using the ODI (Oswestry Disability Index) when comparing the different surgical methods. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary objective is defined as the assessment of clinical outcome using the RMI (Roland Morris Index), COMI (Core Outcome Measures Index), SSpV (Subjective Spine Value) and EQ-5D-3L scores, as well as the VAS (Visual Analog Scale) for pain. | — |
Countries
Germany
Contacts
Public ContactYvonne Noll
Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift
Outcome results
None listed